ID   FT-2
AC   CVCL_5123
SY   FT-2 (TK-)
DR   Wikidata; Q54835214
RX   PubMed=6203516;
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS:0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5125 ! Fu5-5
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
RX   PubMed=6203516; DOI=10.1007/BF00484224;
RA   Killary A.M., Lugo T.G., Fournier R.E.K.;
RT   "Isolation of thymidine kinase-deficient rat hepatoma cells by
RT   selection with bromodeoxyuridine, Hoechst 33258, and visible light.";
RL   Biochem. Genet. 22:201-213(1984).
//